Fortress Biotech, Inc.
FBIO
$1.66
$0.021.22%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 27.09% | -155.04% | 55.81% | 28.42% | 65.57% |
| Total Depreciation and Amortization | -5.62% | -19.65% | 1.19% | -51.13% | -41.85% |
| Total Amortization of Deferred Charges | -40.94% | -40.79% | -38.18% | -5.43% | -10.09% |
| Total Other Non-Cash Items | 80.07% | 30.98% | 48.33% | 43.59% | 62.47% |
| Change in Net Operating Assets | 68.42% | 41.10% | -141.18% | -7.83% | -1,892.00% |
| Cash from Operations | 63.05% | -19.55% | 34.40% | 41.26% | 26.98% |
| Capital Expenditure | -- | -- | -- | -- | 69.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -42,757.14% | -- | -- | -- | 88.33% |
| Cash from Investing | -23,709.52% | -- | -- | -- | 83.89% |
| Total Debt Issued | -65.57% | -- | -- | -- | 190.58% |
| Total Debt Repaid | -786.81% | 94.32% | -- | -- | 102.25% |
| Issuance of Common Stock | -92.75% | 706.01% | -- | 14.53% | 1,169.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -370.59% |
| Total Dividends Paid | 100.00% | 100.00% | 0.00% | 0.00% | -0.05% |
| Other Financing Activities | -6.14% | -511.62% | -5.64% | 35.90% | 16.16% |
| Cash from Financing | -40.84% | 200.97% | 146.95% | 25.56% | 134.28% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -124.37% | -19.93% | 88.48% | 109.50% | 129.10% |